Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection
- Resource Type
- Article
- Source
- In
Vaccine 20 August 2015 33(35):4247-4254 - Subject
- Language
- ISSN
- 0264-410X